San Ramon, CA – RheoSense, Inc., has announced the release of its new viscometer, microVISC‑m. The microVISC-m is designed to simplify daily or routine measurements of oils viscosity, providing the fastest, easiest, and most cost effective way to assess the overall health of lubricating oil.
"Our microVISC-m is an excellent tool for oil-condition monitoring,” said Seong-Gi Baek, Ph.D., RheoSense’s president and CEO. “It is highly portable, easy, fast, and requires only a few drops of oil.”
RheoSense says its microVISC‑m measures oil viscosity through an easy, one-minute test, eliminating the need to wait for test results from remote labs. The instrument requires a sample volume as small as 100 microliters.
The viscometer displays dynamic viscosity at ambient conditions. It also extrapolates kinematic viscosities at 40, 80, and 100 oC, allowing for east determination of oil health while following industry-standard ASTM D341 formulas. The VROC rectangular slit microfluidic cell employed in the viscometer is incredibly fast and easy to use with little to no training, and the data generated with microVISC-m is also stored with date and time stamps for traceability.
“By saving time and sample,” said Baek, “microVISC‑m makes assessing oil health affordable, and easier and quicker than ever. It offers high return on your investment, and is an ideal viscometer for field operators.”
For more information, visit http://www.RheoSense.com/products/viscometers/microvisc-m
-#-
ABOUT RHEOSENSE: A GLOBAL HIGH-TECH INSTRUMENT COMPANY BASED IN SILICON VALLEY
Our innovative m-VROC™ & microVISC™ viscometers feature patented Viscometer/Rheometer-on-a-Chip (VROC®) technology. Utilizing state-of-the-art MEMS (Micro-Electro-Mechanical Systems) and microfluidics breakthroughs, our instruments offer the smallest sample volume per measurement, coupled with exceptional ease of use and accuracy.
We are the leader in providing viscometers to the biotechnology, pharmaceutical, and emerging protein therapeutics industries. RheoSense instruments have been rigorously tested, approved, and adopted worldwide by Fortune Global 500 companies and leading research universities.
COMMENTS